Voyager enters strategic gene therapy collaboration with Genzyme

Read More

SAGE and Voyager highlighted in Forbes neuroscience feature

Read More

Third Rock's Discover, Launch, Build strategy featured in Fortune

Read More

Partner Profile: Cary Pfeffer, M.D.

Read More

Third Rock Launches REVOLUTION Medicines with $45 Million Series A

Read More

Agios and bluebird bio CEOs Named Best CEOs of 2014 by TheStreet.com

Read More

Positive Results Released from Phase 2 Trial of Beloranib in Hypothalamic Injury Associated Obesity

Read More

Partner Alexis Borisy Featured in Re/code Boston Special Series
 

Read More

Partner Charles Homcy Shares the Story of Founding MyoKardia

Watch the Video

Andrew Stricos, who has Huntington’s disease, and his wife tell their story at a luncheon hosted by Third Rock

Watch the Video

Transforming Healthcare

35

Portfolio Companies
With More Than $1.3 Billion
Under Management

30

Clinical Studies
Underway Within Our Portfolio

40

Diseases
Being Targeted By
Our Companies

10  

of thousands

Patients Impacted
By Portfolio Company Products
and Clinical Trials